Abbott Announces Supply Agreement For Needlestick Prevention Products

Article

ABBOTT PARK, IL-Abbott Laboratories has signed a supply agreement for VanishPoint needlestick prevention products. VanishPoint products use patented automated retraction technology, which reduces exposure to contaminated needles.

Once a drug injection or blood draw is complete, the needle automatically retracts from the patient into the barrel of the device.

These products will become part of Abbott's Needlestick Prevention Systems product line.

Abbott already provides hospitals and healthcare facilities with VanishPoint blood collection tube holders under an 18-month agreement and VanishPoint retractable syringes as part of a two-year contract.

Abbott's products satisfy new OSHA prevention directives and the Needlestick Safety and Prevention Act, which became law November 2000.

Newsletter

Stay prepared and protected with Infection Control Today's newsletter, delivering essential updates, best practices, and expert insights for infection preventionists.

Recent Videos
 Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
 Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio
In a recent discussion with Infection Control Today® (ICT®), study authors Brenna Doran PhD, MA, hospital epidemiology and infection prevention for the University of California, San Francisco, and a coach and consultant of infection prevention; Jessica Swain, MBA, MLT, director of infection prevention and control for Dartmouth Health in Lebanon, New Hampshire; and Shanina Knighton, associate professor at Case Western Reserve University School of Nursing and senior nurse scientist at MetroHealth System in Cleveland, Ohio, shared their insights on how the project evolved and what the findings mean for the future.